Citius Pharmaceuticals, Inc. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Citius Pharmaceuticals, Inc. stock issued during period, value, issued for services for the quarter ending 2025-12-31 was $107.51K.
- Citius Pharmaceuticals, Inc. stock issued during period, value, issued for services for the quarter ending 2024-06-30 was $109.95K.
- Citius Pharmaceuticals, Inc. stock issued during period, value, issued for services for the quarter ending 2024-03-31 was $98.08K, a 3.84% decline year-over-year.
- Citius Pharmaceuticals, Inc. stock issued during period, value, issued for services for the quarter ending 2023-12-31 was $76.15K.
- Citius Pharmaceuticals, Inc. stock issued during period, value, issued for services for fiscal 2025 was $26.60K, a 90.64% decline from fiscal 2024.
- Citius Pharmaceuticals, Inc. stock issued during period, value, issued for services for fiscal 2024 was $284.18K, a 178.60% increase from fiscal 2023.
- Citius Pharmaceuticals, Inc. stock issued during period, value, issued for services for fiscal 2023 was $102.00K, a 73.03% decline from fiscal 2022.
- Citius Pharmaceuticals, Inc. stock issued during period, value, issued for services for fiscal 2022 was $378.20K, a 456.18% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2025-12-31 | $107.51K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $26.60K 10-K · filed 2025-12-23 | |
| 2024-09-30 | $284.18K 10-K · filed 2025-12-23 | |
| 2024-06-30 | $109.95K 10-Q · filed 2025-08-12 | |
| 2024-03-31 | $98.08K 10-Q · filed 2025-08-12 | |
| 2023-12-31 | $76.15K 10-Q · filed 2025-08-12 | |
| 2023-09-30 | $102.00K 10-K · filed 2024-12-27 | |
| 2023-03-31 | $102.00K 10-Q · filed 2024-08-12 | |
| 2022-09-30 | $378.20K 10-K · filed 2023-12-29 | |
| 2022-03-31 | $178.00K 10-Q · filed 2023-08-14 | |
| 2021-12-31 | $95.88K 10-Q · filed 2023-08-14 | |
| 2021-09-30 | $68.00K 10-K · filed 2022-12-22 | |
| 2021-03-31 | $68.00K 10-Q · filed 2022-08-11 | |
| 2020-09-30 | $528.77K 10-K · filed 2020-12-16 | |
| 2020-06-30 | $22.75K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $306.02K 10-Q · filed 2021-05-13 | |
| 2019-12-31 | $100.00K 10-Q · filed 2021-05-13 | |
| 2019-09-30 | $211.60K 10-K · filed 2020-12-16 | |
| 2019-03-31 | $117.50K 10-Q · filed 2020-08-14 | |
| 2018-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-11 | $377.20K 10-K · filed 2018-12-11 |
| 2018-06-30 | $31.00K 10-Q · filed 2019-08-14 | $782.45K derived: sum of 4 quarters · filed 2019-12-16 |
| 2018-03-31 | $88.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-11 | $751.45K derived: sum of 4 quarters · filed 2019-12-16 |
| 2017-12-31 | $257.40K 10-Q · filed 2018-02-14 | |
| 2017-09-30 | $405.25K derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-16 | $704.02K 10-K · filed 2019-12-16 |
| 2017-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-14 | |
| 2016-09-30 | $60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-23 | $150.00K 10-K · filed 2016-12-23 |
| 2016-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |